Radcliffe Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-165,205
| Closed | -$1.7M | – | 563 |
|
|
2023
Q2 | $1.7M | Hold |
165,205
| – | – | 0.14% | 193 |
|
|
2023
Q1 | $1.67M | Hold |
165,205
| – | – | 0.1% | 246 |
|
|
2022
Q4 | $1.65M | Hold |
165,205
| – | – | 0.05% | 533 |
|
|
2022
Q3 | $1.61M | Hold |
165,205
| – | – | 0.04% | 740 |
|
|
2022
Q2 | $1.6M | Buy |
165,205
+19,082
| +13% | +$185K | 0.04% | 778 |
|
|
2022
Q1 | $1.42M | Buy |
+146,123
| New | +$1.42M | 0.03% | 813 |
|